Should treatment for heart failure with preserved ejection fraction differ from that for heart failure with reduced ejection fraction?
Jong
Philip
P
Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Canada.
McKelvie
Robert
R
Yusuf
Salim
S
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D013318:Stroke Volume; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors